Telehealth Flexibilities Expiring Dec. 31, 2025

Temporary measures that have broadened Medicare coverage of telehealth since the beginning of the coronavirus pandemic will expire soon, putting providers and some Medicare beneficiaries at risk for interruption in care. During the COVID-19 public health emergency, Congress and HHS temporarily lifted restrictions on telehealth, and many of those temporary measures have...

Telehealth Flexibilities Expiring Dec. 31, 2025 Continue reading…

SAMHSA Issues Guidance on 2024 Final Rule for Opioid Treatment Programs.

Hot of the press! In late November 2024, the Substance Abuse and Mental Health Services Administration released guidance on implementing its 2024 final rule that made some of the most significant updates to standards for the operation of opioid treatment programs and the use of medications to treat opioid use disorder in...

SAMHSA Issues Guidance on 2024 Final Rule for Opioid Treatment Programs. Continue reading…

Contingency Management for Substance Use Disorder Treatment

According to the US Department of Health and Human Services (HHS), contingency management is widely considered the most effective treatment for stimulant use disorder, and also shows promise as an effective treatment for other forms of substance use disorder. Contingency management involves providing incentives — such as modest financial amounts on a gift...

Contingency Management for Substance Use Disorder Treatment Continue reading…

Medi-Cal Guidance for Mobile Narcotic Treatment Programs

DHCS issued guidance in Jan. 2024 for operators of mobile narcotic treatment programs, which are becoming a more effective approach to providing care to persons with opioid use disorder living in remote areas.  The DHCS guidance provides information on the requirements for operating mobile narcotic treatment programs under Medi-Cal.

SAMHSA Tribal Opioid Response Grants –Notice of Funding Opportunity 

The Substance Abuse and Mental Health Services Administration (SAMSHA) published a notice of funding available to assist in addressing the opioid overdose crisis in Tribal communities by increasing access to FDA-approved medications for the treatment of opioid use disorder (MOUD), and supporting the continuum of prevention, harm reduction, treatment, and recovery support...

SAMHSA Tribal Opioid Response Grants –Notice of Funding Opportunity  Continue reading…